• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估台湾结核病应对措施的影响——迈向终结结核病的征程。

Assessing the impact of the TB response in Taiwan - the journey towards ending TB.

作者信息

Chan P-C, Chiang C-Y, Lee P-H, Lo H-Y, Chu P-W, Chen J-J, Kato S, Raviglione M C B

机构信息

Division of Chronic Infectious Diseases, Centers for Disease Control, Taiwan.

Division of Preparedness and Emerging Infectious Diseases, Centers for Disease Control, Taiwan.

出版信息

IJTLD Open. 2025 May 12;2(5):251-259. doi: 10.5588/ijtldopen.25.0103. eCollection 2025 May.

DOI:10.5588/ijtldopen.25.0103
PMID:40365028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12068451/
Abstract

The incidence of TB in Taiwan declined by 62% from 2005 to 2023 (i.e., from 73/100,000 to 28/100,000). Here we review the past two decades of TB epidemiology, policy implementation, and outcomes, identifying gaps and solutions for domestic and global responses. An external review in 2024 assessed National TB Program progress towards the End TB goal, integrating feedback from an International Review Panel and a 2023 expert questionnaire. The findings informed Phase III (2026-2030) of the 'End TB by 2035 Project'. We present review materials, consensus recommendations, and follow-ups through 2024. In 2023, 64% of the TB cases were aged ≥ 65. TB incidence among those < 60 is projected to meet the End TB targets (<10/100,000) by 2035, while elimination (<1 per million) is expected among 0-14-year-olds. During 2005-2024, Taiwan universally adopted new diagnostic tools for drug-resistant TB, shorter regimens and user-friendly platforms for reporting and case management. Nationwide policy innovations included active case finding, and TB infection (TBI) treatment. Taiwan's consistent investment in TB reflects strong political commitment to End TB. Current challenges include aging, co-morbidities, high TB/TBI among foreign migrant workers and societal disparities, and we suggest that future efforts must leverage artificial intelligence, universal genotyping and greater inter-departmental collaboration.

摘要

2005年至2023年期间,台湾地区的结核病发病率下降了62%(即从每10万人73例降至每10万人28例)。在此,我们回顾过去二十年台湾地区结核病的流行病学、政策实施情况及成果,找出国内和全球应对措施中存在的差距并提出解决方案。2024年的一次外部评估对国家结核病规划在实现终止结核病目标方面的进展进行了评估,整合了国际审查小组的反馈意见以及2023年专家调查问卷的结果。这些结果为“2035年终止结核病项目”的第三阶段(2026 - 2030年)提供了参考。我们展示了截至2024年的审查材料、共识建议及后续跟进情况。2023年,64%的结核病病例年龄在65岁及以上。预计到2035年,60岁以下人群的结核病发病率将达到终止结核病目标(低于每10万人10例),而0 - 14岁儿童的结核病发病率预计将实现消除(低于百万分之一)。在2005 - 2024年期间,台湾地区全面采用了耐多药结核病的新诊断工具、更短的治疗方案以及便于报告和病例管理的用户友好平台。全岛性的政策创新包括主动病例发现以及结核病感染(TBI)治疗。台湾地区对结核病的持续投入体现了其对终止结核病的坚定政治承诺。当前面临的挑战包括人口老龄化、合并症、外籍劳工中结核病/TBI高发以及社会差异,我们建议未来的工作必须利用人工智能、普遍基因分型以及加强部门间协作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/6c19c7ac31c9/ijtldopen25-0103f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/00d0a88abaa3/ijtldopen25-0103f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/be881f48e745/ijtldopen25-0103f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/35e62e9a999d/ijtldopen25-0103f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/b59f9ae985ce/ijtldopen25-0103f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/6c19c7ac31c9/ijtldopen25-0103f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/00d0a88abaa3/ijtldopen25-0103f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/be881f48e745/ijtldopen25-0103f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/35e62e9a999d/ijtldopen25-0103f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/b59f9ae985ce/ijtldopen25-0103f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c7/12068451/6c19c7ac31c9/ijtldopen25-0103f5.jpg

相似文献

1
Assessing the impact of the TB response in Taiwan - the journey towards ending TB.评估台湾结核病应对措施的影响——迈向终结结核病的征程。
IJTLD Open. 2025 May 12;2(5):251-259. doi: 10.5588/ijtldopen.25.0103. eCollection 2025 May.
2
Tuberculosis结核病
3
[Tuberculosis in Asia].[亚洲的结核病]
Kekkaku. 2002 Oct;77(10):693-7.
4
Paradigm shift in efforts to end TB by 2025.2025 年终结结核病努力的范式转变。
Indian J Tuberc. 2020 Dec;67(4S):S48-S60. doi: 10.1016/j.ijtb.2020.11.001. Epub 2020 Nov 10.
5
What is operational research and how can national tuberculosis programmes in low- and middle-income countries use it to end TB?什么是运筹学,低收入和中等收入国家的国家结核病规划如何利用它来终结结核病?
Indian J Tuberc. 2020 Dec;67(4S):S23-S32. doi: 10.1016/j.ijtb.2020.11.009. Epub 2020 Nov 23.
6
Advancing tuberculosis elimination in India: A qualitative review of current strategies and areas for improvement in tuberculosis preventive treatment.推进印度的结核病消除工作:对结核病预防性治疗的当前策略及改进领域的定性综述
IJID Reg. 2024 Dec 21;14:100556. doi: 10.1016/j.ijregi.2024.100556. eCollection 2025 Mar.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Lessons and updates from India's National Tuberculosis Elimination Program - bold decisions and innovative ways of fast-tracking progress toward ending tuberculosis.印度国家结核病消除计划的经验与进展——为加速实现终结结核病目标而做出的大胆决策和创新举措。
IJID Reg. 2025 Mar 19;14(Suppl 2):100599. doi: 10.1016/j.ijregi.2025.100599. eCollection 2025 Mar.
9
Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020).印度国家结核病消除规划下(2005-2020 年)耐多药结核病(DR-TB)患者程序性服务和治疗结局的演变历程。
Expert Rev Respir Med. 2021 Jul;15(7):885-898. doi: 10.1080/17476348.2021.1850277. Epub 2021 Jan 21.
10
What will it take to eliminate drug-resistant tuberculosis?消除耐多药结核病需要什么?
Int J Tuberc Lung Dis. 2019 May 1;23(5):535-546. doi: 10.5588/ijtld.18.0217.

本文引用的文献

1
Clofazimine and QT prolongation in the treatment of rifampicin-resistant tuberculosis: Findings of aDSM in Taiwan.氯法齐明与利福平耐药结核病治疗中的 QT 间期延长:来自台湾的 DSM 研究结果。
J Microbiol Immunol Infect. 2024 Oct;57(5):791-800. doi: 10.1016/j.jmii.2024.08.002. Epub 2024 Aug 8.
2
TB notifications among citizens and non-citizens in Taiwan.台湾地区的公民和非公民中的结核病通报。
Int J Tuberc Lung Dis. 2024 Jul 1;28(7):328-334. doi: 10.5588/ijtld.23.0567.
3
Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB elimination.
承诺、伙伴关系与行动研究:11个结核病消除规划国家实现结核病消除的三大优先事项。
IJTLD Open. 2024 Jan 1;1(1):50-55. doi: 10.5588/ijtldopen.23.0470. eCollection 2024 Jan.
4
New priorities for Croatia to pursue tuberculosis pre-elimination.克罗地亚实现结核病消除前期目标的新重点。
Eur Respir J. 2024 Jun 20;63(6). doi: 10.1183/13993003.00279-2024. Print 2024 Jun.
5
Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs.减轻广泛耐药性肺结核治疗失败:新药和已上市药物再利用的作用。
J Microbiol Immunol Infect. 2024 Aug;57(4):617-628. doi: 10.1016/j.jmii.2024.04.008. Epub 2024 Apr 26.
6
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination With Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection Among People With HIV.含整合酶链转移抑制剂的抗逆转录病毒方案联合短程利福平为基础方案治疗 HIV 感染者潜伏性结核感染的治疗反应。
Clin Infect Dis. 2024 May 15;78(5):1295-1303. doi: 10.1093/cid/ciad730.
7
Challenges and opportunities for TB elimination in Suriname.苏里南结核病消除面临的挑战与机遇。
Int J Tuberc Lung Dis. 2023 Dec 1;27(12):946-948. doi: 10.5588/ijtld.23.0309.
8
Incremental yield of serial sputum examinations in the diagnosis of pulmonary tuberculosis in Taiwan: Findings of a pragmatic trial.台湾地区连续痰检在肺结核诊断中的增量效益:一项实用试验的结果。
J Microbiol Immunol Infect. 2023 Dec;56(6):1245-1252. doi: 10.1016/j.jmii.2023.09.006. Epub 2023 Sep 27.
9
The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy.肺结核复发率:标准抗结核治疗疗程及依从性的影响
J Infect Public Health. 2023 Nov;16(11):1778-1783. doi: 10.1016/j.jiph.2023.09.005. Epub 2023 Sep 11.
10
Impact of wars and natural disasters on emerging and re-emerging infectious diseases.战争和自然灾害对新发和再发传染病的影响。
Front Public Health. 2023 Sep 1;11:1215929. doi: 10.3389/fpubh.2023.1215929. eCollection 2023.